<DOC>
	<DOCNO>NCT00533689</DOCNO>
	<brief_summary>THis study aim determine whether frequent dose intravitreal injection Ranibizumab ( Lucentis ) Bevacizumab ( Avastin ) , act VEGF inhibitor , deleterious effect retina , study electrophysiologic testing . This prospective , non-randomized clinical study include patient assigned intravitreal injection Ranibizumab Bevacizumab due neovascular AMD . The patient undergo repeat ophthalmic evaluation intravitreal injection every 4-6 week , long deem necessary . Periodic electrophysiologic evaluation include Electroretinogram ( ERG ) , electro-oculogram ( EOG ) Visual Evoked Potentials ( VEP ) test perform every 3 month .</brief_summary>
	<brief_title>Study Long-Term Effect Frequent Anti-VEGF Dosing Retinal Function Patients With Neovascular AMD</brief_title>
	<detailed_description />
	<criteria>Diagnosis CNV secondary AMD No ocular disease No history keratorefractive surgery No epilepsy Ability perform electrophysiologic study Pregnancy Minority Epilepsy History keratorefractive surgery</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>